Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FS6PE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,218
Award facts
- Contract value 100% obligated
- $46,218.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,218.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen auto-injectors on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's pharmaceutical supply operations under the DLA Troop Support Medical contract vehicle. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems with brand-name and generic medications across multiple therapeutic domains.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The Dupixent supply supports the Defense Health Agency and other federal healthcare systems with this specialty medication used in the treatment of atopic dermatitis and other immunological conditions. AmerisourceBergen's consistent receipt of competitive, non-set-aside awards demonstrates the company's capability to meet federal procurement standards and positions it as a key supplier within the DLA's pharmaceutical prime vendor network.
Quick answers
Who was awarded contract SPE2DB25FS6PE?
SPE2DB25FS6PE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FS6PE worth?
The government has obligated $46,218 on SPE2DB25FS6PE.
Is contract SPE2DB25FS6PE an order under another contract?
Yes. SPE2DB25FS6PE is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6PE competed?
The extent of competition for SPE2DB25FS6PE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award